nodes	percent_of_prediction	percent_of_DWPC	metapath
Phosphatidylserine—PRKCA—cerebellar cortex—malignant glioma	0.0327	0.0791	CbGeAlD
Phosphatidylserine—PRKCA—telencephalic ventricle—malignant glioma	0.019	0.046	CbGeAlD
Phosphatidylserine—SCARB1—endothelium—malignant glioma	0.0185	0.0448	CbGeAlD
Phosphatidylserine—SCARB1—blood vessel—malignant glioma	0.0171	0.0413	CbGeAlD
Phosphatidylserine—PTDSS1—brainstem—malignant glioma	0.0121	0.0293	CbGeAlD
Phosphatidylserine—ATP8A1—telencephalon—malignant glioma	0.0111	0.0269	CbGeAlD
Phosphatidylserine—PRKCA—endothelium—malignant glioma	0.0102	0.0247	CbGeAlD
Phosphatidylserine—SCARB1—embryo—malignant glioma	0.0102	0.0246	CbGeAlD
Phosphatidylserine—PRKCA—blood vessel—malignant glioma	0.00942	0.0228	CbGeAlD
Phosphatidylserine—SCARB1—retina—malignant glioma	0.00901	0.0218	CbGeAlD
Phosphatidylserine—DGKD—retina—malignant glioma	0.00849	0.0205	CbGeAlD
Phosphatidylserine—PISD—retina—malignant glioma	0.00837	0.0202	CbGeAlD
Phosphatidylserine—DGKD—telencephalon—malignant glioma	0.00781	0.0189	CbGeAlD
Phosphatidylserine—PISD—telencephalon—malignant glioma	0.00769	0.0186	CbGeAlD
Phosphatidylserine—DGKG—central nervous system—malignant glioma	0.00689	0.0167	CbGeAlD
Phosphatidylserine—DGKG—cerebellum—malignant glioma	0.00674	0.0163	CbGeAlD
Phosphatidylserine—PTDSS2—medulla oblongata—malignant glioma	0.00664	0.016	CbGeAlD
Phosphatidylserine—SCARB1—medulla oblongata—malignant glioma	0.00651	0.0157	CbGeAlD
Phosphatidylserine—SMPD3—central nervous system—malignant glioma	0.00646	0.0156	CbGeAlD
Phosphatidylserine—ATP8A1—central nervous system—malignant glioma	0.00633	0.0153	CbGeAlD
Phosphatidylserine—SMPD3—cerebellum—malignant glioma	0.00631	0.0153	CbGeAlD
Phosphatidylserine—ATP8A1—cerebellum—malignant glioma	0.00619	0.015	CbGeAlD
Phosphatidylserine—DGKD—medulla oblongata—malignant glioma	0.00614	0.0148	CbGeAlD
Phosphatidylserine—PTDSS1—central nervous system—malignant glioma	0.00611	0.0148	CbGeAlD
Phosphatidylserine—PTDSS2—midbrain—malignant glioma	0.00606	0.0147	CbGeAlD
Phosphatidylserine—PISD—medulla oblongata—malignant glioma	0.00605	0.0146	CbGeAlD
Phosphatidylserine—PTDSS1—cerebellum—malignant glioma	0.00597	0.0144	CbGeAlD
Phosphatidylserine—PTDSS2—spinal cord—malignant glioma	0.00592	0.0143	CbGeAlD
Phosphatidylserine—SMPD4—central nervous system—malignant glioma	0.00591	0.0143	CbGeAlD
Phosphatidylserine—SMPD4—cerebellum—malignant glioma	0.00577	0.014	CbGeAlD
Phosphatidylserine—PRKCA—embryo—malignant glioma	0.00562	0.0136	CbGeAlD
Phosphatidylserine—DGKD—midbrain—malignant glioma	0.00561	0.0136	CbGeAlD
Phosphatidylserine—PISD—midbrain—malignant glioma	0.00553	0.0134	CbGeAlD
Phosphatidylserine—DGKD—spinal cord—malignant glioma	0.00548	0.0132	CbGeAlD
Phosphatidylserine—DGKG—brain—malignant glioma	0.00547	0.0132	CbGeAlD
Phosphatidylserine—PISD—spinal cord—malignant glioma	0.00539	0.013	CbGeAlD
Phosphatidylserine—PRKCA—brainstem—malignant glioma	0.00515	0.0124	CbGeAlD
Phosphatidylserine—SMPD3—brain—malignant glioma	0.00513	0.0124	CbGeAlD
Phosphatidylserine—ATP8A1—brain—malignant glioma	0.00503	0.0122	CbGeAlD
Phosphatidylserine—PRKCA—retina—malignant glioma	0.00497	0.012	CbGeAlD
Phosphatidylserine—PTDSS1—brain—malignant glioma	0.00485	0.0117	CbGeAlD
Phosphatidylserine—PTDSS2—central nervous system—malignant glioma	0.0048	0.0116	CbGeAlD
Phosphatidylserine—SCARB1—central nervous system—malignant glioma	0.00471	0.0114	CbGeAlD
Phosphatidylserine—PTDSS2—cerebellum—malignant glioma	0.00469	0.0113	CbGeAlD
Phosphatidylserine—SMPD4—brain—malignant glioma	0.00469	0.0113	CbGeAlD
Phosphatidylserine—SCARB1—cerebellum—malignant glioma	0.00461	0.0111	CbGeAlD
Phosphatidylserine—PRKCA—telencephalon—malignant glioma	0.00457	0.011	CbGeAlD
Phosphatidylserine—DGKD—central nervous system—malignant glioma	0.00444	0.0107	CbGeAlD
Phosphatidylserine—PISD—central nervous system—malignant glioma	0.00437	0.0106	CbGeAlD
Phosphatidylserine—DGKD—cerebellum—malignant glioma	0.00434	0.0105	CbGeAlD
Phosphatidylserine—PISD—cerebellum—malignant glioma	0.00427	0.0103	CbGeAlD
Phosphatidylserine—PTDSS2—brain—malignant glioma	0.00381	0.00921	CbGeAlD
Phosphatidylserine—SCARB1—brain—malignant glioma	0.00374	0.00904	CbGeAlD
Phosphatidylserine—DGKD—brain—malignant glioma	0.00353	0.00852	CbGeAlD
Phosphatidylserine—PISD—brain—malignant glioma	0.00347	0.00839	CbGeAlD
Phosphatidylserine—PRKCA—midbrain—malignant glioma	0.00328	0.00793	CbGeAlD
Phosphatidylserine—PRKCA—spinal cord—malignant glioma	0.0032	0.00774	CbGeAlD
Phosphatidylserine—PRKCA—central nervous system—malignant glioma	0.0026	0.00628	CbGeAlD
Phosphatidylserine—PRKCA—cerebellum—malignant glioma	0.00254	0.00614	CbGeAlD
Phosphatidylserine—PRKCA—brain—malignant glioma	0.00206	0.00498	CbGeAlD
Phosphatidylserine—PRKCA—EGF/EGFR Signaling Pathway—AKT1—malignant glioma	7.26e-05	0.000124	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by FGFR—AKT1—malignant glioma	7.26e-05	0.000124	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by ERBB2—AKT1—malignant glioma	7.23e-05	0.000123	CbGpPWpGaD
Phosphatidylserine—PRKCA—DAP12 signaling—AKT1—malignant glioma	7.19e-05	0.000123	CbGpPWpGaD
Phosphatidylserine—SMPD4—Metabolism—AKT1—malignant glioma	7.16e-05	0.000122	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—GFAP—malignant glioma	7.16e-05	0.000122	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by NGF—STAT3—malignant glioma	7.15e-05	0.000122	CbGpPWpGaD
Phosphatidylserine—PRKCA—Innate Immune System—BAD—malignant glioma	7.12e-05	0.000121	CbGpPWpGaD
Phosphatidylserine—DGKD—Signaling Pathways—VEGFA—malignant glioma	7.11e-05	0.000121	CbGpPWpGaD
Phosphatidylserine—DGKG—Signaling Pathways—VEGFA—malignant glioma	7.11e-05	0.000121	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by GPCR—KNG1—malignant glioma	7.1e-05	0.000121	CbGpPWpGaD
Phosphatidylserine—PRKCA—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—malignant glioma	7.09e-05	0.000121	CbGpPWpGaD
Phosphatidylserine—DGKD—Signaling Pathways—STAT3—malignant glioma	7.04e-05	0.00012	CbGpPWpGaD
Phosphatidylserine—DGKG—Signaling Pathways—STAT3—malignant glioma	7.04e-05	0.00012	CbGpPWpGaD
Phosphatidylserine—PRKCA—Hemostasis—AKT2—malignant glioma	7e-05	0.000119	CbGpPWpGaD
Phosphatidylserine—PRKCA—Platelet activation, signaling and aggregation—PIK3CA—malignant glioma	6.94e-05	0.000118	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—SPHK1—malignant glioma	6.92e-05	0.000118	CbGpPWpGaD
Phosphatidylserine—PRKCA—Innate Immune System—CD80—malignant glioma	6.9e-05	0.000118	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—JAG1—malignant glioma	6.85e-05	0.000117	CbGpPWpGaD
Phosphatidylserine—PRKCA—Innate Immune System—EGF—malignant glioma	6.81e-05	0.000116	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—HEY1—malignant glioma	6.78e-05	0.000116	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—CCR4—malignant glioma	6.78e-05	0.000116	CbGpPWpGaD
Phosphatidylserine—PRKCA—Innate Immune System—PTPN11—malignant glioma	6.77e-05	0.000115	CbGpPWpGaD
Phosphatidylserine—PRKCA—DAP12 interactions—AKT1—malignant glioma	6.77e-05	0.000115	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by FGFR in disease—AKT1—malignant glioma	6.77e-05	0.000115	CbGpPWpGaD
Phosphatidylserine—PRKCA—Hemostasis—PIK3CD—malignant glioma	6.73e-05	0.000115	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—FBXW7—malignant glioma	6.71e-05	0.000115	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by EGFR—AKT1—malignant glioma	6.71e-05	0.000114	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by EGFR in Cancer—AKT1—malignant glioma	6.65e-05	0.000113	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by PDGF—AKT1—malignant glioma	6.62e-05	0.000113	CbGpPWpGaD
Phosphatidylserine—PRKCA—Gene Expression—NOTCH2—malignant glioma	6.59e-05	0.000112	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—HIST1H3B—malignant glioma	6.59e-05	0.000112	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—GSTT1—malignant glioma	6.56e-05	0.000112	CbGpPWpGaD
Phosphatidylserine—PRKCA—Cell Cycle, Mitotic—CDKN2A—malignant glioma	6.56e-05	0.000112	CbGpPWpGaD
Phosphatidylserine—SMPD3—Metabolism—AKT1—malignant glioma	6.55e-05	0.000112	CbGpPWpGaD
Phosphatidylserine—PTDSS2—Metabolism—AKT1—malignant glioma	6.55e-05	0.000112	CbGpPWpGaD
Phosphatidylserine—DGKD—Signaling Pathways—MYC—malignant glioma	6.55e-05	0.000112	CbGpPWpGaD
Phosphatidylserine—DGKG—Signaling Pathways—MYC—malignant glioma	6.55e-05	0.000112	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by NGF—EGFR—malignant glioma	6.5e-05	0.000111	CbGpPWpGaD
Phosphatidylserine—DGKD—Signaling Pathways—EGFR—malignant glioma	6.4e-05	0.000109	CbGpPWpGaD
Phosphatidylserine—DGKG—Signaling Pathways—EGFR—malignant glioma	6.4e-05	0.000109	CbGpPWpGaD
Phosphatidylserine—PRKCA—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	6.37e-05	0.000109	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—IFNA2—malignant glioma	6.36e-05	0.000108	CbGpPWpGaD
Phosphatidylserine—PRKCA—Innate Immune System—AKT2—malignant glioma	6.3e-05	0.000108	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by GPCR—MMP3—malignant glioma	6.29e-05	0.000107	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—PTGS1—malignant glioma	6.15e-05	0.000105	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by NGF—KRAS—malignant glioma	6.14e-05	0.000105	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by Wnt—MYC—malignant glioma	6.12e-05	0.000104	CbGpPWpGaD
Phosphatidylserine—PTDSS1—Metabolism—AKT1—malignant glioma	6.09e-05	0.000104	CbGpPWpGaD
Phosphatidylserine—PISD—Metabolism—AKT1—malignant glioma	6.09e-05	0.000104	CbGpPWpGaD
Phosphatidylserine—PRKCA—Innate Immune System—PIK3CD—malignant glioma	6.06e-05	0.000103	CbGpPWpGaD
Phosphatidylserine—DGKG—Signaling Pathways—KRAS—malignant glioma	6.05e-05	0.000103	CbGpPWpGaD
Phosphatidylserine—DGKD—Signaling Pathways—KRAS—malignant glioma	6.05e-05	0.000103	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—JAG2—malignant glioma	6.02e-05	0.000103	CbGpPWpGaD
Phosphatidylserine—PRKCA—Hemostasis—RAF1—malignant glioma	6.01e-05	0.000102	CbGpPWpGaD
Phosphatidylserine—PRKCA—NGF signalling via TRKA from the plasma membrane—AKT1—malignant glioma	5.99e-05	0.000102	CbGpPWpGaD
Phosphatidylserine—PRKCA—Cell Cycle—CDKN2A—malignant glioma	5.87e-05	0.0001	CbGpPWpGaD
Phosphatidylserine—PRKCA—Hemostasis—PIK3CB—malignant glioma	5.87e-05	0.0001	CbGpPWpGaD
Phosphatidylserine—PRKCA—Innate Immune System—FGF2—malignant glioma	5.8e-05	9.89e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—BCHE—malignant glioma	5.72e-05	9.75e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism of mRNA—AKT1—malignant glioma	5.71e-05	9.74e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Cell Cycle—MDM2—malignant glioma	5.69e-05	9.7e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Gene Expression—CDKN2B—malignant glioma	5.67e-05	9.67e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Platelet activation, signaling and aggregation—AKT1—malignant glioma	5.67e-05	9.67e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—SLC5A5—malignant glioma	5.65e-05	9.63e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by NGF—PIK3CA—malignant glioma	5.64e-05	9.63e-05	CbGpPWpGaD
Phosphatidylserine—DGKD—Signaling Pathways—PIK3CA—malignant glioma	5.56e-05	9.48e-05	CbGpPWpGaD
Phosphatidylserine—DGKG—Signaling Pathways—PIK3CA—malignant glioma	5.56e-05	9.48e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—PTK2—malignant glioma	5.53e-05	9.44e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Innate Immune System—BCL2—malignant glioma	5.51e-05	9.4e-05	CbGpPWpGaD
Phosphatidylserine—SCARB1—Metabolism—PIK3CA—malignant glioma	5.47e-05	9.34e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Innate Immune System—MDM2—malignant glioma	5.43e-05	9.26e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Innate Immune System—RAF1—malignant glioma	5.41e-05	9.23e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Hemostasis—IL2—malignant glioma	5.39e-05	9.19e-05	CbGpPWpGaD
Phosphatidylserine—DGKG—Signaling Pathways—TP53—malignant glioma	5.38e-05	9.17e-05	CbGpPWpGaD
Phosphatidylserine—DGKD—Signaling Pathways—TP53—malignant glioma	5.38e-05	9.17e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Gene Expression—NCOR1—malignant glioma	5.37e-05	9.17e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Innate Immune System—ERBB2—malignant glioma	5.35e-05	9.13e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Innate Immune System—PIK3CB—malignant glioma	5.28e-05	9.01e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—CDKN2B—malignant glioma	5.26e-05	8.98e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—PDGFRA—malignant glioma	5.18e-05	8.83e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—HLA-B—malignant glioma	5.14e-05	8.77e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—H3F3A—malignant glioma	5.09e-05	8.68e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—GPCR downstream signaling—F2—malignant glioma	5.05e-05	8.62e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—CXCR3—malignant glioma	5.04e-05	8.6e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—HES1—malignant glioma	5.02e-05	8.56e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—NCOR1—malignant glioma	4.99e-05	8.51e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—NTRK2—malignant glioma	4.9e-05	8.37e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—YWHAE—malignant glioma	4.9e-05	8.37e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism of RNA—AKT1—malignant glioma	4.89e-05	8.33e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—FLT1—malignant glioma	4.88e-05	8.33e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—DUSP6—malignant glioma	4.86e-05	8.29e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—GPCR downstream signaling—PIK3CG—malignant glioma	4.84e-05	8.25e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—JAG1—malignant glioma	4.8e-05	8.19e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—NOTCH3—malignant glioma	4.78e-05	8.15e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—PDGFRA—malignant glioma	4.78e-05	8.15e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—HLA-A—malignant glioma	4.76e-05	8.13e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—FBXW7—malignant glioma	4.7e-05	8.02e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—PDGFB—malignant glioma	4.65e-05	7.93e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—FGFR1—malignant glioma	4.63e-05	7.89e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—BDKRB2—malignant glioma	4.61e-05	7.87e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by NGF—AKT1—malignant glioma	4.61e-05	7.86e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by GPCR—F2—malignant glioma	4.59e-05	7.83e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Hemostasis—VEGFA—malignant glioma	4.58e-05	7.81e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Innate Immune System—PTEN—malignant glioma	4.56e-05	7.78e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—GSTP1—malignant glioma	4.55e-05	7.76e-05	CbGpPWpGaD
Phosphatidylserine—DGKG—Signaling Pathways—AKT1—malignant glioma	4.54e-05	7.74e-05	CbGpPWpGaD
Phosphatidylserine—DGKD—Signaling Pathways—AKT1—malignant glioma	4.54e-05	7.74e-05	CbGpPWpGaD
Phosphatidylserine—SCARB1—Metabolism—AKT1—malignant glioma	4.47e-05	7.63e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Cell Cycle, Mitotic—MYC—malignant glioma	4.45e-05	7.58e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—GPCR downstream signaling—AKT2—malignant glioma	4.43e-05	7.55e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—CAT—malignant glioma	4.43e-05	7.55e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—TERT—malignant glioma	4.4e-05	7.5e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—HLA-A—malignant glioma	4.4e-05	7.5e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by GPCR—PIK3CG—malignant glioma	4.39e-05	7.49e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by GPCR—PTPN11—malignant glioma	4.32e-05	7.36e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—PDGFB—malignant glioma	4.29e-05	7.32e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—NOTCH2—malignant glioma	4.29e-05	7.31e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—FGFR1—malignant glioma	4.27e-05	7.29e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—GPCR downstream signaling—PIK3CD—malignant glioma	4.25e-05	7.25e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by Wnt—AKT1—malignant glioma	4.25e-05	7.24e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—HIF1A—malignant glioma	4.21e-05	7.18e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—KNG1—malignant glioma	4.2e-05	7.16e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—NCOR1—malignant glioma	4.18e-05	7.13e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—BAD—malignant glioma	4.14e-05	7.07e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Gene Expression—NOTCH1—malignant glioma	4.08e-05	6.96e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—CAV1—malignant glioma	4.07e-05	6.94e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—CD80—malignant glioma	4.02e-05	6.86e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by GPCR—AKT2—malignant glioma	4.02e-05	6.86e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—NTRK1—malignant glioma	4e-05	6.82e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Cell Cycle—MYC—malignant glioma	3.97e-05	6.78e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—EGF—malignant glioma	3.97e-05	6.77e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—PTPN11—malignant glioma	3.94e-05	6.73e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Hemostasis—KRAS—malignant glioma	3.89e-05	6.64e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by GPCR—PIK3CD—malignant glioma	3.86e-05	6.59e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Gene Expression—PPARG—malignant glioma	3.85e-05	6.57e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—BAD—malignant glioma	3.83e-05	6.53e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—NOTCH1—malignant glioma	3.79e-05	6.46e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—MMP3—malignant glioma	3.72e-05	6.34e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—CD80—malignant glioma	3.71e-05	6.33e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Innate Immune System—EGFR—malignant glioma	3.71e-05	6.33e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—GPCR downstream signaling—PIK3CB—malignant glioma	3.71e-05	6.32e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—APC—malignant glioma	3.71e-05	6.32e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—CDKN2B—malignant glioma	3.68e-05	6.29e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—AKT2—malignant glioma	3.67e-05	6.26e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—EGF—malignant glioma	3.66e-05	6.25e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—PTPN11—malignant glioma	3.64e-05	6.21e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—PTK2—malignant glioma	3.58e-05	6.1e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Hemostasis—PIK3CA—malignant glioma	3.58e-05	6.1e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—GPCR downstream signaling—CXCL8—malignant glioma	3.56e-05	6.08e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—PIK3CD—malignant glioma	3.53e-05	6.02e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—HES1—malignant glioma	3.51e-05	6e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Innate Immune System—KRAS—malignant glioma	3.5e-05	5.98e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—NCOR1—malignant glioma	3.49e-05	5.96e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—BRAF—malignant glioma	3.48e-05	5.94e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Hemostasis—TP53—malignant glioma	3.46e-05	5.9e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by GPCR—RAF1—malignant glioma	3.45e-05	5.88e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—CAV1—malignant glioma	3.41e-05	5.81e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—GPCR downstream signaling—IL2—malignant glioma	3.4e-05	5.81e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—AKT2—malignant glioma	3.39e-05	5.78e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—FGF2—malignant glioma	3.38e-05	5.76e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by GPCR—PIK3CB—malignant glioma	3.37e-05	5.74e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—PDGFRA—malignant glioma	3.35e-05	5.71e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Cell Cycle—TP53—malignant glioma	3.26e-05	5.57e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—PIK3CD—malignant glioma	3.26e-05	5.56e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—SPP1—malignant glioma	3.25e-05	5.54e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by GPCR—CXCL8—malignant glioma	3.23e-05	5.52e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Innate Immune System—PIK3CA—malignant glioma	3.22e-05	5.49e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—BCL2—malignant glioma	3.21e-05	5.47e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—IFNG—malignant glioma	3.18e-05	5.42e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—MDM2—malignant glioma	3.16e-05	5.39e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—RAF1—malignant glioma	3.15e-05	5.37e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—FGF2—malignant glioma	3.12e-05	5.32e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—ERBB2—malignant glioma	3.12e-05	5.32e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—PIK3CG—malignant glioma	3.1e-05	5.29e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by GPCR—IL2—malignant glioma	3.09e-05	5.27e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—TERT—malignant glioma	3.08e-05	5.25e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—PIK3CB—malignant glioma	3.08e-05	5.25e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—PDGFB—malignant glioma	3.01e-05	5.13e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—PPARG—malignant glioma	3e-05	5.11e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—FGFR1—malignant glioma	2.99e-05	5.1e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—HIF1A—malignant glioma	2.95e-05	5.02e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Hemostasis—AKT1—malignant glioma	2.92e-05	4.98e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—MDM2—malignant glioma	2.92e-05	4.98e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—RAF1—malignant glioma	2.91e-05	4.96e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—ERBB2—malignant glioma	2.88e-05	4.91e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—CAV1—malignant glioma	2.85e-05	4.86e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—PIK3CB—malignant glioma	2.84e-05	4.84e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—IL1B—malignant glioma	2.84e-05	4.84e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—IL2—malignant glioma	2.82e-05	4.82e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—KDR—malignant glioma	2.82e-05	4.81e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—PTGS2—malignant glioma	2.81e-05	4.8e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—PIK3CD—malignant glioma	2.73e-05	4.65e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—F2—malignant glioma	2.71e-05	4.63e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—FN1—malignant glioma	2.71e-05	4.63e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—BAD—malignant glioma	2.68e-05	4.57e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—PTEN—malignant glioma	2.66e-05	4.53e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—NOTCH1—malignant glioma	2.65e-05	4.53e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Innate Immune System—AKT1—malignant glioma	2.63e-05	4.49e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—CD80—malignant glioma	2.6e-05	4.43e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—APC—malignant glioma	2.59e-05	4.43e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—PIK3CG—malignant glioma	2.59e-05	4.43e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—EGF—malignant glioma	2.57e-05	4.38e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—PTPN11—malignant glioma	2.55e-05	4.35e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—PTEN—malignant glioma	2.45e-05	4.19e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—BRAF—malignant glioma	2.44e-05	4.16e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—PIK3CB—malignant glioma	2.38e-05	4.06e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—STAT3—malignant glioma	2.38e-05	4.05e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—AKT2—malignant glioma	2.37e-05	4.05e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by GPCR—EGFR—malignant glioma	2.36e-05	4.03e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—PTGS2—malignant glioma	2.36e-05	4.02e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—PIK3CD—malignant glioma	2.28e-05	3.89e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—GPCR downstream signaling—PIK3CA—malignant glioma	2.26e-05	3.85e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by GPCR—KRAS—malignant glioma	2.23e-05	3.81e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Gene Expression—MYC—malignant glioma	2.2e-05	3.75e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—STAT3—malignant glioma	2.19e-05	3.74e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—FGF2—malignant glioma	2.18e-05	3.73e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—EGFR—malignant glioma	2.16e-05	3.68e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—PTEN—malignant glioma	2.05e-05	3.51e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by GPCR—PIK3CA—malignant glioma	2.05e-05	3.5e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—MDM2—malignant glioma	2.04e-05	3.49e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—KRAS—malignant glioma	2.04e-05	3.48e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—MYC—malignant glioma	2.04e-05	3.48e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—RAF1—malignant glioma	2.04e-05	3.47e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—ERBB2—malignant glioma	2.01e-05	3.44e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—EGFR—malignant glioma	1.99e-05	3.4e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—PIK3CB—malignant glioma	1.99e-05	3.39e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—CXCL8—malignant glioma	1.91e-05	3.26e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—KRAS—malignant glioma	1.88e-05	3.21e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—PIK3CA—malignant glioma	1.87e-05	3.2e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—GPCR downstream signaling—AKT1—malignant glioma	1.85e-05	3.15e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—CASP3—malignant glioma	1.83e-05	3.12e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—IL2—malignant glioma	1.83e-05	3.12e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—PIK3CA—malignant glioma	1.73e-05	2.95e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—MMP9—malignant glioma	1.73e-05	2.95e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—PTEN—malignant glioma	1.72e-05	2.93e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling by GPCR—AKT1—malignant glioma	1.68e-05	2.86e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—VEGFA—malignant glioma	1.55e-05	2.65e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—STAT3—malignant glioma	1.54e-05	2.62e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Immune System—AKT1—malignant glioma	1.53e-05	2.61e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Gene Expression—AKT1—malignant glioma	1.52e-05	2.6e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—PIK3CA—malignant glioma	1.45e-05	2.47e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—MYC—malignant glioma	1.43e-05	2.44e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Disease—AKT1—malignant glioma	1.41e-05	2.41e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—EGFR—malignant glioma	1.4e-05	2.38e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—KRAS—malignant glioma	1.32e-05	2.25e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—PIK3CA—malignant glioma	1.21e-05	2.07e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Metabolism—AKT1—malignant glioma	1.18e-05	2.02e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—TP53—malignant glioma	1.17e-05	2e-05	CbGpPWpGaD
Phosphatidylserine—PRKCA—Signaling Pathways—AKT1—malignant glioma	9.9e-06	1.69e-05	CbGpPWpGaD
